Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abingworth
Biotech
Myricx secures $114M series A to push ADCs into clinic
Myricx is focused on the inhibition of NMT, which adds a specific lipid modification to certain protein targets key to the survival of cancer cells.
James Waldron
Jul 8, 2024 1:00am
Abingworth channels $356M into late-stage clinical programs
Oct 30, 2023 10:55am
Nearing clinic, AI-driven Iambic posts $100M round, Nvidia pact
Oct 4, 2023 10:05am
Carlyle's Abingworth buy brings $2 billion for life sciences
Apr 12, 2022 10:00am
Abingworth, Pfizer back $61M gene therapy delivery round
Sep 16, 2021 2:00am
Takeda norovirus vaccine spinout HilleVax snags $135M crossover
Sep 8, 2021 10:25am
